| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 640.91B | — |
| Operating expense | — | — |
| Net income | 141.83B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ALPMY returned +30.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +13.1% |
| 1 year | +30.8% |
| 5 years | -6.1% |
| 10 years | +3.2% |
| All-time high | $17.84 (May 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ALPMY would be worth today ›No. Astellas Pharma Inc. has not paid a dividend in the past 12 months.
Astellas Pharma Inc. is part of the Healthcare sector.
Astellas Pharma Inc. has a market cap of 26.95B USD, based on the latest quote.
Astellas Pharma Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
